Late-Breaking Phase 3 Data at AAD 2023 Show Oral Investigational Medicine Deuruxolitinib Significantly Improved Scalp Hair Regrowth in Alopecia Areata

MUMBAI, India and PRINCETON, N.J. , March 18, 2023 /PRNewswire/ — Concert Pharmaceuticals (“Concert”), a company recently acquired by Sun Pharmaceutical Industries Limited (including its subsidiaries and/or associated companies, “Sun Pharma”), today announced the presentation of data…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.